CVS Health Corp (BSP:CVSH34)
R$ 31.75 -0.09 (-0.28%) Market Cap: 403.33 Bil Enterprise Value: 794.75 Bil PE Ratio: 9.69 PB Ratio: 0.92 GF Score: 76/100

CVS Health Corp at Morgan Stanley Global Healthcare Conference Transcript

Sep 12, 2023 / 12:50PM GMT
Release Date Price: R$34.98 (+6.97%)
Erin Elizabeth Wilson Wright
Morgan Stanley, Research Division - Equity Analyst

Good morning, everyone. My name is Erin Wright, I'm the lead healthcare services analyst at Morgan Stanley.

Just real quickly. For more important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com. If you have any questions, please reach out to your Morgan Stanley sales representative.

And with that, we're happy to have CVS health with us this morning. With them, we have Karen Lynch, President and CEO, thank you; as well as Shawn Guertin, EVP and CFO. And then we have Larry McGrath in the audience as well.

So I will hand it over to you, Shawn, for your disclosures now.

Shawn Michael Guertin
CVS Health Corporation - President of Health Services, Executive VP & CFO

Great, thank you. Thank you, good morning, everyone. I just want to remind everyone today that we will be making forward-looking statements today, and you should consult our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot